Rivastigmine hydrogen tartrate is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and Parkinson's disease.
Rivastingmine Hydrogen Tartrate
Description | |
---|---|
(2S,3S)-2,3-dihydroxybutanedioic acid; [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate | |
129101-54-8 | |
C18H28N2O8 | |
Exelon; Rivastigmine; Rivastigmine Tartrate | |
Nootropic & Alzheimer’s treatment |